Marketwatch.com / Biotech, Biomedical



Domain overview in Biotech, Biomedical niche. Based on relevant links and pages only.
marketwatch.com rank
213
Number of domains linking to marketwatch.com
3
semantic flow
0.09
Number of links to marketwatch.com
4
semantic flow
0.09
Number of domains linked from marketwatch.com
26
semantic flow
16.51
Number of links from marketwatch.com
438
semantic flow
16.51

Popular pages pointing to marketwatch.com

Pages with highest topical PageRank pointing to domain.

url / atext / target url
https://www.xconomy.com/boston/2014/05/01/merrimack-heads-to-fda-as-pancreatic-cancer-drug
top line results from a 417 patient late stage study of mm 398
http://www.marketwatch.com/story/merrimack-pharmaceuticals-announces-mm-398-achieves-prima
www.xconomy.com
https://www.marketwatch.com/investing/stock/axon
axovant to move stock exchange listing to nasdaq
https://www.marketwatch.com/story/axovant-to-move-stock-exchange-listing-to-nasdaq-2017-08
https://www.marketwatch.com/investing/stock/axon
alzheimer s disease 2017
https://www.marketwatch.com/story/alzheimers-disease-2017-2017-11-28
https://www.marketwatch.com/investing/stock/axon
analyst estimates
https://www.marketwatch.com/investing/stock/axon/analystestimates
https://www.marketwatch.com/investing/stock/axon
earnings review and free research report axovant sciences reported lower than expected earnings
https://www.marketwatch.com/story/earnings-review-and-free-research-report-axovant-science
https://www.marketwatch.com/investing/stock/axon
sec filings
https://www.marketwatch.com/investing/stock/axon/secfilings
https://www.marketwatch.com/investing/stock/pti
proteostasis therapeutics inc nasdaq pti to ring the nasdaq stock market opening bell
https://www.marketwatch.com/story/proteostasis-therapeutics-inc-nasdaqpti-to-ring-the-nasd
https://www.marketwatch.com/investing/stock/pti
proteostasis therapeutics files investigational new drug application for pti 808 cystic fibrosis potentiator
https://www.marketwatch.com/story/proteostasis-therapeutics-files-investigational-new-drug
https://www.marketwatch.com/investing/stock/axon
news
https://www.marketwatch.com/investing/stock/axon/news
https://www.marketwatch.com/investing/stock/axon
featured company news aveo pharma s fotivda r licensed in eu for the treatment of advanced renal cell
https://www.marketwatch.com/story/featured-company-news---aveo-pharmas-fotivdar-licensed-i

Popular pages from marketwatch.com

On-topic pages from domain with highest topical PageRank.

title / url
PR


info
relevance


info
links


info
rel links


info
external links


info
external domains


info
referring domains


info
external backlinks


info
AXON Stock Price - Axovant Sciences Ltd. Stock Quote (U.S.: Nasdaq) - MarketWatch
https://www.marketwatch.com/investing/stock/axon
0.280.981655621700
Biotech ETFs tumble as Celgeneu2019s quarterly results and outlook weigh - MarketWatch
https://www.marketwatch.com/story/biotech-etfs-tumble-as-celgenes-quarterly-results-and-ou
0.280.9962131100
MBRX Stock Price - Moleculin Biotech Inc. Stock Quote (U.S.: Nasdaq) - MarketWatch
https://www.marketwatch.com/investing/stock/mbrx
0.191142409300

Popular prospect pages from marketwatch.com

On-topic pages from domain with highest topical PageRank having a few outgoing links and domains.

title / url
PR


info
relevance


info
links


info
rel links


info
external links


info
external domains


info
referring domains


info
external backlinks


info
AXON Stock Price - Axovant Sciences Ltd. Stock Quote (U.S.: Nasdaq) - MarketWatch
https://www.marketwatch.com/investing/stock/axon
0.280.981655621700

Domains with most semantic flow to marketwatch.com

Relevant domains with most links to selected domain.

domain info
count


info
semantic flow


info
http://xconomy.com/ 20.09xconomy.com
http://benzinga.com/ 10.01benzinga.com
http://wsj.com/ 10wsj.com

Most linked pages from marketwatch.com

Pages from domain with most relevant inbound links.

url
count


info
PR


info
score


info
semantic flow


info
relevance


info
on topic


info
links


info
rel links


info
external links


info
external domains


info
referring domains


info
external backlinks


info
https://www.marketwatch.com/investing/fund/xbi 10.160.910.061yes1756924700
https://www.marketwatch.com/search?q= 10.160.930.06-1--1-1-1-100
https://www.marketwatch.com/game 10.160.910.06-1no-1-1-1-100
https://www.marketwatch.com/investing/stock/juno 10.160.920.060.98yes1767128700
https://www.marketwatch.com/investing/stock/celg 10.160.890.060.74yes1734617600
https://www.marketwatch.com/story/these-5-companies-could-disappear-in-2018s-wave-of-ma-20 10.160.890.06-1no-1-1-1-100
https://www.marketwatch.com/newsviewer 10.160.750.05-1no-1-1-1-100
https://www.marketwatch.com/investing/stock/bmrn 10.160.910.050.95yes1795922500
https://www.marketwatch.com/companyinfo 10.160.660.04-1--1-1-1-100
https://www.marketwatch.com/investing 10.160.520.03-1--1-1-1-100

Hubs from marketwatch.com

Pages from domain with most likely on-topic outgoing links.

url
count


info
PR


info
score


info
semantic flow


info
relevance


info
on topic


info
links


info
rel links


info
external links


info
external domains


info
referring domains


info
external backlinks


info
https://www.marketwatch.com/investing/fund/xbi 480.160.912.511yes1756924700
https://www.marketwatch.com/investing/stock/blue 390.160.892.240.98yes1686224700
https://www.marketwatch.com/investing/stock/juno 380.160.921.970.98yes1767128700
https://www.marketwatch.com/investing/stock/cara 380.160.91.080.68yes1584415700
https://www.marketwatch.com/investing/stock/celg 310.160.891.060.74yes1734617600
https://www.marketwatch.com/investing/stock/bmrn 290.160.911.370.95yes1795922500
https://www.marketwatch.com/story/five-biotech-buyout-candidates-you-should-look-at-right- 230.150.921.261yes108236400
https://www.marketwatch.com/newsviewer 50.160.750-1no-1-1-1-100
https://www.marketwatch.com/investing/stocks 40.160.890-1no-1-1-1-100
https://www.marketwatch.com/story/these-5-companies-could-disappear-in-2018s-wave-of-ma-20 30.160.890.01-1no-1-1-1-100

contact | terms | privacy
© 2018-2024 semanticjuice.com